<p>卡路美（Calumet Specialty Products Partners, L.P.）（NASDAQ:CLMT - 获取免费报告）在周一的交易中上涨了 4.6%。该公司的股价最高达到 10.93 美元，最后交易价为 10.97 美元。在交易中，共成交 38,669 股，较平均交易量 831,847 股下降了 95%。该股票此前收盘价为 10.48 美元。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>2 只能源股因十亿美元的能源部贷款承诺而飙升</li>
</ul>
<p>几位股票研究分析师最近对 CLMT 股票发表了看法。富国银行将卡路美的股票目标价从 28.00 美元下调至 23.00 美元，并在 4 月 9 日的研究报告中给予该公司 “增持” 评级。瑞银集团将卡路美的评级从 “卖出” 上调至 “中性”，并在 3 月 17 日的报告中将其目标价从 15.00 美元下调至 12.00 美元。HC Wainwright 在 3 月 3 日的报告中重申了 “买入” 评级，并对卡路美的股票设定了 33.00 美元的目标价。最后，TD Cowen 将卡路美的评级从 “买入” 下调至 “持有”，并在 3 月 4 日的报告中将其目标价从 26.00 美元下调至 16.00 美元。一位分析师对该股票给予了 “卖出” 评级，两位分析师给予了 “持有” 评级，三位分析师给予了 “买入” 评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “持有”，共识目标价为 19.80 美元。</p>
<p><strong>查看我们对 CLMT 的最新分析</strong></p>
<h2>卡路美股票上涨 4.7%</h2>
<p>该公司的 50 日简单移动平均线为 11.90 美元，200 日简单移动平均线为 17.24 美元。公司的市值为 9.428 亿美元，市盈率为-3.97，贝塔值为 1.42。</p>
<p>卡路美（Calumet Specialty Products Partners）（NASDAQ:CLMT - 获取免费报告）最近于 2 月 28 日发布了其财报。这家石油和天然气公司报告本季度每股收益（EPS）为-0.47 美元，超出分析师一致预期的-1.06 美元，超出幅度为 0.59 美元。该季度的营业收入为 9.495 亿美元，而分析师预期为 9.2176 亿美元。去年同期，该公司每股收益为-0.59 美元。卡路美本季度的收入同比下降了 2.8%。分析师预计卡路美将在本财年发布-3.02 美元的每股收益。</p>
<h2>内部交易活动</h2>
<p>在其他卡路美的新闻中，首席财务官 David Lunin 于 3 月 4 日（星期二）购买了 2,500 股该公司的股票，交易价格为每股 13.05 美元，总价值为 32,625.00 美元。交易完成后，首席财务官现在直接持有该公司 2,500 股股票，价值 32,625 美元。这笔交易代表了其持股的∞增长。该购买在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。此外，董事 Stephen P. Mawer 于 3 月 24 日（星期一）出售了 3,655 股该公司的股票，交易价格为每股 12.88 美元，总交易额为 47,076.40 美元。出售后，该董事现在直接持有 287,307 股该公司股票，价值 3,700,514.16 美元。这笔交易代表了其持股的 1.26% 减少。该出售的披露信息可以在这里找到。公司内部人士目前持有该股票的 2.91%。</p>
<h2>关于卡路美</h2>
<p>（获取免费报告）</p>
<p>卡路美公司从事多样化的特种品牌产品和可再生燃料的制造、配方和营销，客户涵盖广泛的消费市场和工业市场。它通过以下几个部门运营：特种产品与解决方案、性能品牌、蒙大拿州/可再生能源和公司业务。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过卡路美</li>
<li>超买股票解析：你应该交易它们吗？</li>
<li>2025 年最佳防御股票... 到目前为止</li>
<li>投资石油股票的方式和原因</li>
<li>字母表在强劲财报和回购公告后反弹</li>
<li>3 只值得考虑的股息王</li>
<li>出售台积电会是巴菲特最大的遗憾吗？</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在卡路美吗？</h2>
<p>在考虑卡路美之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买... 而卡路美并不在名单上。</p>
<p>虽然卡路美目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

卡路美

<p>Calumet Specialty Products Partners（纳斯达克代码：CLMT）股价上涨 4.6%，至 10.97 美元，尽管交易量显著下降。分析师意见不一，富国银行将其目标价下调至 23.00 美元，而 HC Wainwright 则维持买入评级，目标价为 33.00 美元。该公司报告的季度每股收益为（0.47 美元），超出预期，但收入同比下降 2.8%。内部交易活动包括首席财务官 David Lunin 购买股票，而董事 Stephen P. Mawer 则出售了一部分持股。该股票的共识评级为 “持有”，目标价为 19.80 美元</p>

<p>Shares of Calumet Specialty Products Partners, L.P. (NASDAQ:CLMT - Get Free Report) shot up 4.6% during trading on Monday . The company traded as high as $10.93 and last traded at $10.97. 38,669 shares traded hands during trading, a decline of 95% from the average session volume of 831,847 shares. The stock had previously closed at $10.48.</p>
<div class="lb-trans"><p>卡路美（Calumet Specialty Products Partners, L.P.）（NASDAQ:CLMT - 获取免费报告）在周一的交易中上涨了 4.6%。该公司的股价最高达到 10.93 美元，最后交易价为 10.97 美元。在交易中，共成交 38,669 股，较平均交易量 831,847 股下降了 95%。该股票此前收盘价为 10.48 美元。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments</li>
</ul>
<div class="lb-trans"><ul>
<li>2 只能源股因十亿美元的能源部贷款承诺而飙升</li>
</ul>
</div><p>Several equities research analysts have recently weighed in on CLMT shares. Wells Fargo &amp; Company lowered their price target on shares of Calumet Specialty Products Partners from $28.00 to $23.00 and set an &#34;overweight&#34; rating for the company in a research report on Wednesday, April 9th. UBS Group upgraded Calumet Specialty Products Partners from a &#34;sell&#34; rating to a &#34;neutral&#34; rating and lowered their target price for the stock from $15.00 to $12.00 in a report on Monday, March 17th. HC Wainwright reiterated a &#34;buy&#34; rating and issued a $33.00 target price on shares of Calumet Specialty Products Partners in a report on Monday, March 3rd. Finally, TD Cowen downgraded Calumet Specialty Products Partners from a &#34;buy&#34; rating to a &#34;hold&#34; rating and lowered their price target for the company from $26.00 to $16.00 in a report on Tuesday, March 4th. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Hold&#34; and a consensus price target of $19.80.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 CLMT 股票发表了看法。富国银行将卡路美的股票目标价从 28.00 美元下调至 23.00 美元，并在 4 月 9 日的研究报告中给予该公司 “增持” 评级。瑞银集团将卡路美的评级从 “卖出” 上调至 “中性”，并在 3 月 17 日的报告中将其目标价从 15.00 美元下调至 12.00 美元。HC Wainwright 在 3 月 3 日的报告中重申了 “买入” 评级，并对卡路美的股票设定了 33.00 美元的目标价。最后，TD Cowen 将卡路美的评级从 “买入” 下调至 “持有”，并在 3 月 4 日的报告中将其目标价从 26.00 美元下调至 16.00 美元。一位分析师对该股票给予了 “卖出” 评级，两位分析师给予了 “持有” 评级，三位分析师给予了 “买入” 评级。根据 MarketBeat 的数据，该公司目前的共识评级为 “持有”，共识目标价为 19.80 美元。</p>
</div><p><strong>View Our Latest Analysis on CLMT</strong></p>
<div class="lb-trans"><p><strong>查看我们对 CLMT 的最新分析</strong></p>
</div><h2>Calumet Specialty Products Partners Stock Up 4.7 %</h2>
<div class="lb-trans"><h2>卡路美股票上涨 4.7%</h2>
</div><p>The firm's 50 day simple moving average is $11.90 and its 200 day simple moving average is $17.24. The company has a market cap of $942.80 million, a price-to-earnings ratio of -3.97 and a beta of 1.42.</p>
<div class="lb-trans"><p>该公司的 50 日简单移动平均线为 11.90 美元，200 日简单移动平均线为 17.24 美元。公司的市值为 9.428 亿美元，市盈率为-3.97，贝塔值为 1.42。</p>
</div><p>Calumet Specialty Products Partners (NASDAQ:CLMT - Get Free Report) last released its earnings results on Friday, February 28th. The oil and gas company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.06) by $0.59. The business had revenue of $949.50 million during the quarter, compared to analysts' expectations of $921.76 million. During the same quarter in the previous year, the company earned ($0.59) EPS. Calumet Specialty Products Partners's revenue for the quarter was down 2.8% on a year-over-year basis. Analysts anticipate that Calumet Specialty Products Partners, L.P. will post -3.02 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>卡路美（Calumet Specialty Products Partners）（NASDAQ:CLMT - 获取免费报告）最近于 2 月 28 日发布了其财报。这家石油和天然气公司报告本季度每股收益（EPS）为-0.47 美元，超出分析师一致预期的-1.06 美元，超出幅度为 0.59 美元。该季度的营业收入为 9.495 亿美元，而分析师预期为 9.2176 亿美元。去年同期，该公司每股收益为-0.59 美元。卡路美本季度的收入同比下降了 2.8%。分析师预计卡路美将在本财年发布-3.02 美元的每股收益。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In other Calumet Specialty Products Partners news, CFO David Lunin acquired 2,500 shares of the business's stock in a transaction dated Tuesday, March 4th. The shares were acquired at an average price of $13.05 per share, with a total value of $32,625.00. Following the completion of the transaction, the chief financial officer now directly owns 2,500 shares in the company, valued at $32,625. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Stephen P. Mawer sold 3,655 shares of the company's stock in a transaction on Monday, March 24th. The stock was sold at an average price of $12.88, for a total transaction of $47,076.40. Following the sale, the director now directly owns 287,307 shares in the company, valued at $3,700,514.16. This trade represents a 1.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.91% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他卡路美的新闻中，首席财务官 David Lunin 于 3 月 4 日（星期二）购买了 2,500 股该公司的股票，交易价格为每股 13.05 美元，总价值为 32,625.00 美元。交易完成后，首席财务官现在直接持有该公司 2,500 股股票，价值 32,625 美元。这笔交易代表了其持股的∞增长。该购买在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。此外，董事 Stephen P. Mawer 于 3 月 24 日（星期一）出售了 3,655 股该公司的股票，交易价格为每股 12.88 美元，总交易额为 47,076.40 美元。出售后，该董事现在直接持有 287,307 股该公司股票，价值 3,700,514.16 美元。这笔交易代表了其持股的 1.26% 减少。该出售的披露信息可以在这里找到。公司内部人士目前持有该股票的 2.91%。</p>
</div><h2>About Calumet Specialty Products Partners</h2>
<div class="lb-trans"><h2>关于卡路美</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products &amp; Solutions, Performance Brands, Montana/Renewables, and Corporate.</p>
<div class="lb-trans"><p>卡路美公司从事多样化的特种品牌产品和可再生燃料的制造、配方和营销，客户涵盖广泛的消费市场和工业市场。它通过以下几个部门运营：特种产品与解决方案、性能品牌、蒙大拿州/可再生能源和公司业务。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Calumet Specialty Products Partners</li>
<li>Overbought Stocks Explained: Should You Trade Them?</li>
<li>Best Defense Stocks in 2025... So Far</li>
<li>The How And Why of Investing in Oil Stocks</li>
<li>Alphabet Rebounds After Strong Earnings and Buyback Announcement</li>
<li>3 Dividend Kings To Consider</li>
<li>Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过卡路美</li>
<li>超买股票解析：你应该交易它们吗？</li>
<li>2025 年最佳防御股票... 到目前为止</li>
<li>投资石油股票的方式和原因</li>
<li>字母表在强劲财报和回购公告后反弹</li>
<li>3 只值得考虑的股息王</li>
<li>出售台积电会是巴菲特最大的遗憾吗？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Calumet Specialty Products Partners Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在卡路美吗？</h2>
</div><p>Before you consider Calumet Specialty Products Partners, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑卡路美之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Calumet Specialty Products Partners wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前进行购买... 而卡路美并不在名单上。</p>
</div><p>While Calumet Specialty Products Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然卡路美目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

卡路美特种产品合伙公司（纳斯达克代码：CLMT）股价上涨 4.6% - 仍然是买入的好时机吗？